Impact of testosterone therapy on major cardiovascular risk in erectil | RRU
To evaluate major adverse cardiovascular events in ED patients who received TRT compared with those who did not
Related Articles
Rahul Banarjee: Excited to moderate the fiercest myeloma debate – OncoDaily
Rahul Banarjee: Excited to moderate the fiercest myeloma debate / Ajai Chari, Amrita Krishnan, Caitlin Costello, cancer, Hearn Jay Cho, Joshua Richter, Krina
Veganism: A resolution for health, planet, and compassion
Beyond being a dietary choice, veganism offers transformative benefits for personal health, environmental sustainability, and animal welfare. As the year winds down, it is natural…
The 13 Biggest Mistakes To Avoid When Cooking Vegan
Going vegan can be overwhelming at first, and many people deal with similar pitfalls. Find out how to fix the most common mistakes when cooking…
What if every pet was vegan? Here’s how much it would help the planet
If every dog ate a vegan diet, it would prevent the equivalent of the UK’s annual CO₂ emissions.
Eating too much protein could lead to heart disease, new study says
We often hear about the benefits of eating more protein, from building muscle to reducing hunger. However, new research is
The Impact of Lifestyle Intervention Programs on Long-Term Cardiac Event-Free Survival in Patients With Established Coronary Artery Disease
Coronary artery disease (CAD) is a leading global cause of morbidity and mortality, necessitating comprehensive approaches for its management. This systematic review evaluates the long-term…
Dr. Ramalingam on How LAURA Established a ‘New Standard of Care’ | Docwire News
Dr. Ramalingam presented results from the LAURA trial during a plenary session, garnering a major reaction from the practice-changing data.
Study Provides Insights on Hospice Access, Use in Patients With Bladder Cancer | Cancer Nursing Today
There was a “steady increase” in the use of hospice for patients with bladder cancer from 2003-2020, but there were variations across races, ages, and…
The Truth About Liquid Biopsies With Christian Rolfo
Christian Rolfo, MD, PhD, of Mount Sinai Medical Center (now at Ohio State as Chief of Oncology), explores the science and clinical applications of liquid…
Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab – PubMed
Exposure to very low levels of LDL cholesterol, achieved via PCSK9 inhibition and statin therapy, was not associated with cognitive impairment through long-term follow-up. Further…